Created for disease state education on the molecular pathways underlying osteoporosis. Sclerostin is one of many factors that affects the downregulation of osteoblasts and overactivity of osteoclasts. The resulting imbalance can lead to fragility fractures in patients with osteoporosis.
Keywords: Animation, 3D, Cell biology / Histology, Molecular Biology, Orthopaedics, Pharmacology, Mechanism of Action (MOA)
AXS Studio Inc.